[02199695-CF] CAS 62893-20-3 | Cefoperazone, sodium salt, USP | MP bio
... people are viewing this right now
02199695-CF | CAS 62893-20-3 | Cefoperazone, sodium salt, USP | MPBIO
Key Features and Details
Cefoperazone Sodium Salt
| SKU | 02199695-CF |
| Alternate Names | Cefobid; Cefoperazone sodium; CPZ; T-1551; [6R-[6.alpha.,7.beta.(R*)]]-7- [[[[(4-Ethyl-2,3- dioxo-1-piperazinyl) carbonyl]amino] (4-hydroxyphenyl) acetyl] amino]-3- [[(1-methyl-1H-tetrazol-5-yl) thio] methyl]- 8-oxo-5- thia-1-azabicyclo[4.2.0] oct-2-ene-2- carboxylic acid; 7-[D-(-)-alpha- (4-ethyl-2,3-dioxo- 1-piperazinecarboxamido)- alpha-(4-hydroxyphenyl) acetamido]- 3-[[(1-methyl-1H- tetrazol-5-yl) thio] methyl]-3-cephem-4- carboxylic acid |
| Application Notes | Cefoperazone sodium salt is used to study drug-protein binding, expression and inhibition of penicillin-binding proteins (PBPs) during cell wall synthesis. |
| Base Catalog Number | 199695 |
| Beilstein Registry Number | 4902135 |
| Biochemical Physiological Actions | Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis. Cefoperazone has a dual excretory pattern, primarily via the biliary system and secondarily via the kidney |
| CAS # | 62893-20-3 |
| EC Number | 263-751-5 |
| Format | Powder |
| Grade | USP |
| Hazard Statements | H317-H334 |
| Molecular Formula | C25H26N9NaO8S2 |
| Molecular Weight | 667.648 g/mol |
| pKa | 4.5 – 6.5 |
| Preparation Method | P261-P280-P342+P311 |
| Source | Soluble in water (50 mg/mL – clear; faint yellow solution). |
| Storage | BIOCHEMICALS |
| Usage Statement | Unless specified otherwise, MP Biomedical’s products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
